We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Sansure Biotech Inc

Sansure Biotech is an integrated solutions manufacturer and provider of diagnostic reagents, nucleic acid diagnostic ... read more Featured Products: More products

Download Mobile App





Sansure Presents Future of Pathogen Identification and Disease Diagnosis

By LabMedica International staff writers
Posted on 07 Feb 2024
Print article
Image: Advanced diagnostics solutions for various infections highlighted at Medlab Middle East 2024 (Photo courtesy of Sansure)
Image: Advanced diagnostics solutions for various infections highlighted at Medlab Middle East 2024 (Photo courtesy of Sansure)

Sansure Biotech (Hunan, China) is highlighting its advanced diagnostic solutions for respiratory tract infection, HPV infection, reproductive tract infection, blood-borne infection and gastrointestinal infection at Medlab Middle East 2024.

Sansure is introducing Surelite – its first CE-IVDR-certified automated CLIA system. The Surelite 8 and Surelite 16 are compact automated CLIA systems that deliver rapid and accurate diagnostic results in as fast as 15 minutes. The smart design, featuring an all-in-one cartridge and a broad spectrum of assays, matches various clinical demands with no extra consumables and no waste. Visitors to the Sansure booth at Medlab Middle East 2024 can also experience the iPonatic III Portable Molecular Workstation alongside the Q-POC Platform. iPonatic III, born in the age of the pandemic, is now finding application in the diagnosis of various infections, including respiratory tract infection (RTI), sexually transmitted infection (STI), and more. On the other hand, the Q-POC Platform is a molecular diagnosis instrument that offers accurate PCR results within 25 minutes. The multiple target points facilitate the testing and evaluation of severe and critical cases.

At Medlab Middle East 2024, Sansure is highlighting its high-throughput, high-precision extraction systems which enable a complete workflow of sample preprocessing and nucleic acid extraction. The Natch CS2 fully automated nucleic acid extraction system is a powerful nucleic acid purification system with an extremely simple workflow. Similarly, the Natch 48 nucleic acid extraction system with advanced magnetic bead technology makes it easy to operate this automatic nucleic acid extractor. Among other products on display at the show is the MA-6000 real-time fluorescence quantitative PCR system equipped with innovative hardware, structure, and optimized software to deliver higher-quality results. MA-6000 ensures extraordinary detection sensitivity, extends the application of thermal cycler from nucleic acid to biotinylated protein, and expands a brand new path for multiplex diagnosis in the clinical field.

Related Links:
Sansure Biotech

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
MEDLAB 2024
Copyright © 2000-2024 Globetech Media. All rights reserved.